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The cardiac sodium channel NaV1.5 initiates the action potential (AP)
and is essential for conduction. The last three residues of NaV1.5 (Ser-Ile-
Val) constitute a PDZ domain-binding motif (SIV) that interacts with PDZ
proteins such as syntrophin proteins and SAP97 defining distinct subsets
of NaV1.5 multi-protein complexes, respectively at the lateral membrane
and the intercalated discs (ID) of cardiomyocytes. Previous results with
dystrophin-deficient mice showed that disruption of the dystrophin-syntro-
phin macromolecular complex impairs excitability and impulse propaga-
tion by reducing the expression of NaV1.5 and syntrophin at the lateral
membrane of cardiomyocytes. Recently, we investigated the in vivo role of
the NaV1.5 SIV motif by characterizing mice bearing a truncation of this
motif (ΔSIV). Western blots of ΔSIV hearts displayed reduced levels of
NaV1.5, which corresponded to a 35% decrease in cardiomyocyte whole-
cell INa and AP upstroke velocity. Immunostainings revealed a specific loss
of NaV1.5 channels in ΔSIV cardiomyocytes at lateral membranes concom-
itant to a 60% decrease in INa recorded at the lateral membrane. However,
NaV1.5 expression at ID and T-tubules was not altered. No INa decrease
was observed at the ID. Epicardial mapping of ΔSIV hearts showed
decreased conduction velocity that manifested as prolongation of the QRS
interval in ECGs. When SAP97 expression was constitutively suppressed
in the heart of knock-out mice, INa and AP maximal upstroke velocity were
unchanged. However, AP duration was greatly increased, suggesting that
the expression and function of other ion channels is modified. These data
reflect the in vivo significance of the PDZ-domain-binding SIV motif in
correct expression of NaV1.5 channels at the lateral membrane and under-
line the functional role of lateral NaV1.5 channels in cardiac conduction.
In addition, the results confirm the existence of distinct pools of
NaV1.5 channels within the cardiomyocytes and suggest a complex regula-
tion and organization of the NaV1.5 pool at the ID, where compensatory
mechanisms could be developped when SAP97 expression is constitutively
suppressed.
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Voltage-gated Na+ (Nav) channels are key determinants of myocar-
dial excitability and defects in Nav channel functioning or regulation,
associated with inherited and acquired cardiac disease, increase the risk
of life-threatening arrhythmias. In heart failure, the inactivation gating
properties of Nav1.5 channels are altered, resulting in decreased channel
availability and increased late Na+ current. Although previous studies
have suggested roles for CaMKII- and SGK1-dependent Nav1.5 phos-
phorylation sites, the global native phosphorylation pattern of Nav1.5
channels associated with these pathophysiological alterations is
unknown. Mass spectrometric (MS)-based phosphoproteomic analyses
were undertaken to identify in situ the native phosphorylation sites on
the Nav1.5 protein purified from ventricles isolated from WT and CaM-
KIIdc-Tg mice overexpressing CaMKIIdc in the heart. Quantitative anal-
yses of Nav1.5 phosphopeptides allowed comparing the relative
abundances of Nav1.5 phosphorylation sites in CaMKIIdc-Tg, versus
WT, ventricles. A total of seventeen Nav1.5 phosphorylation sites were
identified, seven of which are novel as compared with those reported in
our previous MS analyses. Thirteen of these sites are located in the first
loop, one in the second loop, one in the N-terminus and two in the C-
terminus of Nav1.5. Interestingly, out of these seventeen phosphorylation
sites, the C-terminal phosphoserine pS1938 is present in the CaMKIIdc-Tg IPs
(n=3/4) and absent in the WT IPs (n=0/4), and pS1989 is 9-fold more
represented (p<0.05, n=4 in each condition) in the CaMKIIdc-Tg, com-
pared with the WT, IPs. Additionally, three phosphoserines at positions
483, 484 and 664 conform to the consensus phosphorylation sequence of
SGK1. These analyses (1) provide seven novel native cardiac Nav1.5
phosphorylation sites, and (2) identify five Nav1.5 phosphorylation sites
as potential critical determinants of the pathophysiological alterations of
Nav1.5 channels in heart failure.
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Trafficking of ion channels in cardiomyocytes is a highly dynamic
process which is determinant for shaping action potential. In this study,
we focused on the dynamic of Kv1.5 channel which carry the atria-spe-
cific potassium outward current implicated in the repolarisation of the
action potential. We first investigated the endocytosis pathway for Kv1.5
channels in the atria. High resolution 3-D microscopy revealed that
Kv1.5 channels are associated with clathrin vesicles in atrial myocytes
but not with caveolin. Electron microscopy showed that vesicles are
found both at the lateral sarcolemma and at the intercalated disc.
Blockade of the clathrin pathway using hypertonic media or SiRNA
induced an increase in IKur recorded by whole-cell patch-clamp and an
accumulation of Kv1.5 channels at the sarcolemma as shown by biotinyl-
ation assay. Clathrin blockade also increased fluorescence recovery after
photobleaching of Kv1.5 channels. Altogether, these data show that
Kv1.5 channels are internalized through the clathrin pathway. Our objec-
tive now is to investigate the kinetics of Kv1.5 channel internalization in
living atrial myocytes. Total Internal Reflection Fluorescence micros-
copy approach will be used to follow eGFPKv1.5-Kv1.5 channels in
living cells and to establish their dynamic in control and clathrin-blocked
myocytes. To deplete sub-membrane stores of Kv1.5 channels, atrial
myocytes will be exposed to shear-stress and endocytosis will be fol-
lowed for 30 min. The fate of internalized channels will be investigated
at different time points by co-immunostainings with antibodies directed
against the different endosomes. In conclusion, we have identified the
clathrin pathway as the internalization route for Kv1.5 channel, in atrial
myocytes. Future work will be conducted to further investigate dynamic
and fate of this atria-specific channel. This study should help under-
standing the constitution of the sub-membrane reservoir of repolarization
that we previously described. 
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Cardiac sodium channel is a complex which includes the pore-
forming alpha subunit and regulatory proteins that allow sodium influx
during the depolarization phase of the ventricular action potential. The
alpha subunit, Nav1.5, is encoded by SCN5A. Mutations in this gene are
responsible for a wide spectrum of hereditary arrhythmias such as car-
diac conduction disease and atrial fibrillation. A mutation in SCN5A,
leading to a p.I141V substitution, was identified in a large multigenera-
tional family with an arrhythmia syndrome resembling catecholaminergic
polymorphic ventricular tachycardia through whole-exome sequencing.
The purpose of this study was to identify the molecular mechanisms
linking the p.I141V mutation to this arrhythmia. To evaluate the inci-
dence of this substitution on Nav1.5 function, whole-cell patch-clamp
experiments were performed on HEK293 cells transfected with the
human alpha and beta subunits. The presence of the p.I141V mutation
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shifted the voltage-dependence of steady state activation towards more
negative potentials. Thus, we studied the effect of this mutation on the
sodium window current. Compared to the WT, the p.I141V window cur-
rent exhibited a larger peak and this peak was shifted towards more neg-
ative potentials. To investigate the functional consequences of the
cardiac hyperexcitability due to the p.I141V mutation, we incorporated
biophysical properties of the mutant into atrial, Purkinje and ventricular
cell models. The computational analyses imply that the biophysical
changes caused by the p.I141V mutation accelerates the spontaneous rate
in the Purkinje cell model, and reduce the excitation threshold leading to
an increase of the excitability of the cardiac cells. In conclusion, the
present study demonstrates that mutations in SCN5A also may result in
exercise-induced polymorphic ventricular premature complexes and
tachycardia resembling CPVT.
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